No Data
No Data
Express News | Soleno Therapeutics Inc - Set to Join Russell 3000 Index
Soleno Therapeutics Set to Join Russell 3000 Index
REDWOOD CITY, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases,
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
NVIDIA has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance ranking.
Stifel Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $59
Stifel analyst Dae Gon Ha maintains $Soleno Therapeutics(SLNO.US)$ with a buy rating, and maintains the target price at $59.According to TipRanks data, the analyst has a success rate of 36.2% and a to
Piper Sandler Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $93
Piper Sandler analyst Yasmeen Rahimi maintains $Soleno Therapeutics(SLNO.US)$ with a buy rating, and maintains the target price at $93.According to TipRanks data, the analyst has a success rate of 35.
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Soleno Therapeutics (SLNO)